SCHEMBL4100773

SCHEMBL4100773

CCOc1ccc2c(c1)c(C(=O)C(=O)Nc1ccnc(C)c1)c(C(F)(F)F)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.45
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 2/20 0.36
KCNH2 Q12809 1/20 0.36
TP53 P04637 1/20 0.35
PLA2G2A P14555 1/20 0.35
NR2E1 Q9Y466 1/20 0.34
SMARCA2 P51531 1/20 0.34
SMARCA4 P51532 1/20 0.34
F2RL3 Q96RI0 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
PTGS2 P35354 1/20 0.34
ALOX5AP P20292 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2999781 0.93 FAAH (0.43) FAAHMEN1POLBKMT2ASMN1; SMN2
SCHEMBL4101968 0.93 FAAH (0.49) FAAHMEN1KMT2ASMN1; SMN2USP2
SCHEMBL4100722 0.92 FAAH (0.47) FAAHSMN1; SMN2USP2LMNATP53
SCHEMBL3005046 0.92 FAAH (0.41) FAAHMEN1POLBKMT2ASMN1; SMN2
SCHEMBL4100733 0.91 FAAH (0.55) FAAHLMNAMAPTPLA2G2AALOX5AP
SCHEMBL4083379 0.90 FAAH (0.53) FAAHSMN1; SMN2USP2LMNAKCNH2
SCHEMBL3003646 0.90 FAAH (0.47) FAAHMEN1POLBKMT2ASMN1; SMN2
SCHEMBL3010861 0.90 MEN1 (0.44) FAAHMEN1POLBKMT2ASMN1; SMN2
SCHEMBL4088941 0.89 FAAH (0.45) FAAHMEN1KMT2ASMN1; SMN2USP2
SCHEMBL4384201 0.89 FAAH (0.53) FAAHSMN1; SMN2USP2LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed
EP-2049520-A2 INDOLE COMPOUNDS Ironwood Pharmaceuticals, Inc. (US) 2009-04-22 EP disclosed
WO-2008019357-A2 INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885MEN1 4573/4885POLB 4121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.